AlphaMadera's AlphaVal page computes Fabrinet's fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag FN as undervalued, fairly valued, or overvalued.

What is Fabrinet's fair value?

Fair value for FN is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value FN?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from FN's most recent reported fundamentals.

FN - Fabrinet

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $653.00 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Platform & Compounding FCF 85% confidence

Primary model: Two-stage FCF DCF

Valuation Signal Overvalued Strong

Trading 125.9% above fair value

Current Price $703.86

Bear Case $208.13 70.4% downside ($208.13 - $703.86) / $703.86 = -70.4% 10% stage 1 growth, 11% discount

Fair Value $311.60 55.7% downside ($311.60 - $703.86) / $703.86 = -55.7% 16% stage 1 growth, 11% discount

Bull Case $429.80 38.9% downside ($429.80 - $703.86) / $703.86 = -38.9% 21% stage 1 growth, 11% discount

Adjust Assumptions

DCF Stage 1 Growth Rate

16.0%

Discount Rate (WACC)

11.0%

Terminal Growth Rate

3.0%

Key Value Driver

FCF growth rate (16% base case)

Terminal Value % of EV 44%

Implied Market Multiple 133.6x

Plain-Language Summary

Our base-case estimate uses a two-stage discounted cash flow model based on free cash flow. We then blend that result with the average analyst price target of $653.00 from 24 analysts, using a 25% weight on analyst consensus. That produces an estimated intrinsic value of $311.60 per share.

Warnings

ℹ Wall Street's average price target is $653.00 (from 24 analysts). Our estimate is 70% below the consensus -- consider that gap carefully.

Key Risks

P/E alone misleads — earnings depressed by growth investment
Cyclical or commodity businesses may be misclassified as platforms
Terminal value dominance suggests sensitivity to long-run assumptions